mRNA therapy for Surfactant deficiencies (ReCode Therapeutics)

N/A

Report date: 2025/01/26 17:25:56
NME

Base Information

Drug NamemRNA therapy for Surfactant deficiencies (ReCode Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > OligonucleotideSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecode Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A